
INBIOGEN CO.,Ltd — Investor Relations & Filings
INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]주주총회소집결의 | 2026-05-21 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 주주총회소집결의 | 2026-04-20 | Korean | |
| 주주명부폐쇄기간또는기준일설정 | 2026-04-20 | Korean | |
| 정기주주총회결과 | 2026-03-31 | Korean | |
| [기재정정]사업보고서 (2025.12) | 2026-03-31 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46712534 | [기재정정]주주총회소집결의 | 2026-05-21 | Korean | ||
| 46366899 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 34689562 | 주주총회소집결의 | 2026-04-20 | Korean | ||
| 34689561 | 주주명부폐쇄기간또는기준일설정 | 2026-04-20 | Korean | ||
| 33119961 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33119914 | [기재정정]사업보고서 (2025.12) | 2026-03-31 | Korean | ||
| 33119874 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-31 | Korean | ||
| 33014956 | 감사보고서제출 | 2026-03-23 | Korean | ||
| 33014448 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
| 32953517 | 주주총회소집공고 | 2026-03-16 | Korean | ||
| 32953393 | [기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경 | 2026-03-16 | Korean | ||
| 32953388 | 주주총회소집결의 | 2026-03-16 | Korean | ||
| 32848596 | 임시주주총회결과 | 2026-02-27 | Korean | ||
| 19466234 | 매출액또는손익구조30%(대규모법인은15%)이상변경 | 2026-02-12 | Korean | ||
| 19466226 | [기재정정]주주총회소집결의 | 2026-02-12 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
INBIOGEN CO.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16235/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16235 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16235 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16235 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16235}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for INBIOGEN CO.,Ltd (id: 16235)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.